{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,14]],"date-time":"2025-04-14T08:40:09Z","timestamp":1744620009090,"version":"3.40.4"},"reference-count":100,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,14]],"date-time":"2025-04-14T00:00:00Z","timestamp":1744588800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,4,14]],"date-time":"2025-04-14T00:00:00Z","timestamp":1744588800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["BD\/138542\/2018","PTDC\/MED-PAT\/2582\/2021"],"award-info":[{"award-number":["BD\/138542\/2018","PTDC\/MED-PAT\/2582\/2021"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003086","name":"Eusko Jaurlaritza","doi-asserted-by":"publisher","award":["POS_2020_1_0008"],"award-info":[{"award-number":["POS_2020_1_0008"]}],"id":[{"id":"10.13039\/501100003086","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Merck Serono KGaA","award":["Grant for Multiple Sclerosis Innovation 2017"],"award-info":[{"award-number":["Grant for Multiple Sclerosis Innovation 2017"]}]},{"DOI":"10.13039\/501100005765","name":"Universidade de Lisboa","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005765","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neuroimmune Pharmacol"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Multiple Sclerosis (MS) is the leading inflammatory and non-traumatic cause of disability in young adults, with late-onset MS emerging in middle-aged patients often resulting in poorer treatment responses and worse prognoses. The calcium-binding protein S100B is elevated in MS patients, and its targeting has shown promise in reducing disease severity in experimental autoimmune encephalomyelitis (EAE) models. However, most studies on MS pathology have focused on young animal models, leaving a gap in understanding the effects of age and S100B ablation on disease progression throughout the lifespan. This study aimed to characterize EAE in mice of different ages, examining demyelination, inflammation, and immune responses to determine whether S100B ablation could mitigate MS pathogenesis across the lifespan. EAE was induced in six cohorts of C57BL\/6 mice: young adults (3\u00a0months), older adults (6\u00a0months), and middle-aged (12\u00a0months), including corresponding S100B knockout (KO) groups, followed for 23\u00a0days. Upon sacrifice, spinal cords were assessed via immunohistochemistry and Real-Time qPCR, while splenocytes were analyzed for immune cell characterization. Results indicated a more severe disease course in 12-month-old mice, marked by increased gliosis, inflammation, and impaired microglial phagocytic activity. Notably, S100B absence reduced gliosis and inflammatory markers across all ages, with 12-month-old S100B KO mice showing increased regulatory T cells. These findings highlight the exacerbating role of age and elevated S100B in MS progression, underscoring the importance of identifying age-specific MS markers and therapeutic targets.<\/jats:p>\n          <jats:p>\n            <jats:bold>Graphical Abstract<\/jats:bold>\n          <\/jats:p>","DOI":"10.1007\/s11481-025-10195-5","type":"journal-article","created":{"date-parts":[[2025,4,14]],"date-time":"2025-04-14T07:02:07Z","timestamp":1744614127000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Experimental autoimmune encephalomyelitis pathogenesis alters along animal age: impact of S100B expression"],"prefix":"10.1007","volume":"20","author":[{"given":"Ana Rita","family":"Ribeiro","sequence":"first","affiliation":[]},{"given":"Raquel","family":"Pereira","sequence":"additional","affiliation":[]},{"given":"Catarina","family":"Barros","sequence":"additional","affiliation":[]},{"given":"Andreia","family":"Barateiro","sequence":"additional","affiliation":[]},{"given":"Ainhoa","family":"Alberro","sequence":"additional","affiliation":[]},{"given":"Afonso P.","family":"Basto","sequence":"additional","affiliation":[]},{"given":"Lu\u00eds","family":"Gra\u00e7a","sequence":"additional","affiliation":[]},{"given":"Maria Vaz","family":"Pinto","sequence":"additional","affiliation":[]},{"given":"F\u00e1bio M. F.","family":"Santos","sequence":"additional","affiliation":[]},{"given":"Pedro M. P.","family":"Gois","sequence":"additional","affiliation":[]},{"given":"Susan E.","family":"Howlett","sequence":"additional","affiliation":[]},{"given":"Adelaide","family":"Fernandes","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2025,4,14]]},"reference":[{"key":"10195_CR1","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1038\/s41586-021-03892-7","volume":"597","author":"M Absinta","year":"2021","unstructured":"Absinta M, Maric D, Gharagozloo M, Garton T, Smith MD, Jin J, Fitzgerald KC, Song A, Liu P, Lin J-P, Wu T, Johnson KR, McGavern DB, Schafer DP, Calabresi PA, Reich DS (2021) A lymphocyte\u2013microglia\u2013astrocyte axis in chronic active multiple sclerosis. Nature 597:709\u2013714","journal-title":"Nature"},{"key":"10195_CR2","doi-asserted-by":"publisher","first-page":"14319","DOI":"10.1038\/s41598-021-93590-1","volume":"11","author":"S Acharjee","year":"2021","unstructured":"Acharjee S, Gordon PMK, Lee BH, Read J, Workentine ML, Sharkey KA, Pittman QJ (2021) Characterization of microglial transcriptomes in the brain and spinal cord of mice in early and late experimental autoimmune encephalomyelitis using a RiboTag strategy. Sci Rep 11:14319","journal-title":"Sci Rep"},{"key":"10195_CR3","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.jneuroim.2013.06.001","volume":"262","author":"R Aharoni","year":"2013","unstructured":"Aharoni R, Aricha R, Eilam R, From I, Mizrahi K, Arnon R, Souroujon MC, Fuchs S (2013) Age dependent course of EAE in Aire\u2212\/\u2212 mice. J Neuroimmunol 262:27\u201334","journal-title":"J Neuroimmunol"},{"key":"10195_CR4","doi-asserted-by":"publisher","first-page":"5904","DOI":"10.3390\/ijms22115904","volume":"22","author":"R Aharoni","year":"2021","unstructured":"Aharoni R, Eilam R, Arnon R (2021) Astrocytes in Multiple Sclerosis\u2014Essential Constituents with Diverse Multifaceted Functions. Int J Mol Sci 22:5904","journal-title":"Int J Mol Sci"},{"key":"10195_CR5","doi-asserted-by":"publisher","first-page":"e158153","DOI":"10.1172\/jci.insight.158153","volume":"7","author":"JR Atkinson","year":"2022","unstructured":"Atkinson JR, Jerome AD, Sas AR, Munie A, Wang C, Ma A, Arnold WD, Segal BM (2022) Biological aging of CNS-resident cells alters the clinical course and immunopathology of autoimmune demyelinating disease. JCI Insight 7:e158153","journal-title":"JCI Insight"},{"key":"10195_CR6","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1007\/s12026-013-8422-y","volume":"56","author":"E Ballanti","year":"2013","unstructured":"Ballanti E, Perricone C, Greco E, Ballanti M, Di Muzio G, Chimenti MS, Perricone R (2013) Complement and autoimmunity. Immunol Res 56:477\u2013491","journal-title":"Immunol Res"},{"key":"10195_CR7","doi-asserted-by":"publisher","first-page":"3976","DOI":"10.1007\/s12035-015-9336-6","volume":"53","author":"A Barateiro","year":"2016","unstructured":"Barateiro A, Afonso V, Santos G, Cerqueira JJ, Brites D, van Horssen J, Fernandes A (2016) S100B as a Potential Biomarker and Therapeutic Target in Multiple Sclerosis. Mol Neurobiol 53:3976\u20133991","journal-title":"Mol Neurobiol"},{"key":"10195_CR8","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.3390\/healthcare11111585","volume":"11","author":"K Barmpagiannos","year":"2023","unstructured":"Barmpagiannos K, Theotokis P, Petratos S, Pagnin M, Einstein O, Kesidou E, Boziki M, Artemiadis A, Bakirtzis C, Grigoriadis N (2023) The Diversity of Astrocyte Activation during Multiple Sclerosis: Potential Cellular Targets for Novel Disease Modifying Therapeutics. Healthcare 11:1585","journal-title":"Healthcare"},{"key":"10195_CR9","doi-asserted-by":"publisher","first-page":"fcac076","DOI":"10.1093\/braincomms\/fcac076","volume":"4","author":"C Barros","year":"2022","unstructured":"Barros C, Barateiro A, Neto A, Soromenho B, Basto AP, Mateus JM, Xapelli S, Sebasti\u00e3o AM, Brites D, Gra\u00e7a L, Fernandes A (2022) S100B inhibition protects from chronic experimental autoimmune encephalomyelitis. Brain Commun 4:fcac076","journal-title":"Brain Commun"},{"key":"10195_CR10","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1189\/jlb.3RI0716-335R","volume":"102","author":"A Bektas","year":"2017","unstructured":"Bektas A, Schurman SH, Sen R, Ferrucci L (2017) Human T cell immunosenescence and inflammation in aging. J Leukoc Biol 102:977\u2013988","journal-title":"J Leukoc Biol"},{"key":"10195_CR11","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1002\/glia.20935","volume":"58","author":"JL Berard","year":"2010","unstructured":"Berard JL, Wolak K, Fournier S, David S (2010) Characterization of relapsing-remitting and chronic forms of experimental autoimmune encephalomyelitis in C57BL\/6 mice. Glia 58:434\u2013445","journal-title":"Glia"},{"key":"10195_CR12","doi-asserted-by":"publisher","first-page":"566892","DOI":"10.3389\/fimmu.2020.566892","volume":"11","author":"DM Borucki","year":"2020","unstructured":"Borucki DM, Toutonji A, Couch C, Mallah K, Rohrer B, Tomlinson S (2020) Complement-Mediated Microglial Phagocytosis and Pathological Changes in the Development and Degeneration of the Visual System. Front Immunol 11:566892","journal-title":"Front Immunol"},{"key":"10195_CR13","doi-asserted-by":"publisher","first-page":"1104552","DOI":"10.3389\/fneur.2022.1104552","volume":"13","author":"M Boziki","year":"2023","unstructured":"Boziki M, Theotokis P, Kesidou E, Karafoulidou E, Konstantinou C, Michailidou I, Bahar Y, Altintas A, Grigoriadis N (2023) Sex, aging and immunity in multiple sclerosis and experimental autoimmune encephalomyelitis: An intriguing interaction. Front Neurol 13:1104552","journal-title":"Front Neurol"},{"key":"10195_CR14","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1177\/1352458518805246","volume":"25","author":"DJ Burrows","year":"2019","unstructured":"Burrows DJ, McGown A, Jain SA, De Felice M, Ramesh TM, Sharrack B, Majid A (2019) Animal models of multiple sclerosis: From rodents to zebrafish. Mult Scler J 25:306\u2013324","journal-title":"Mult Scler J"},{"key":"10195_CR15","doi-asserted-by":"publisher","first-page":"829331","DOI":"10.3389\/fneur.2022.829331","volume":"13","author":"MC Buscarinu","year":"2022","unstructured":"Buscarinu MC, Reni\u00e8 R, Morena E, Romano C, Bellucci G, Marrone A, Bigi R, Salvetti M, Ristori G (2022) Late-Onset MS: Disease Course and Safety-Efficacy of DMTS. Front Neurol 13:829331","journal-title":"Front Neurol"},{"key":"10195_CR16","doi-asserted-by":"publisher","first-page":"1207617","DOI":"10.3389\/fneur.2023.1207617","volume":"14","author":"N Capasso","year":"2023","unstructured":"Capasso N, Virgilio E, Covelli A, Giovannini B, Foschi M, Montini F, Nasello M, Nilo A, Prestipino E, Schir\u00f2 G, Sperandei S, Clerico M, Lanzillo R (2023) Aging in multiple sclerosis: from childhood to old age, etiopathogenesis, and unmet needs: a narrative review. Front Neurol 14:1207617","journal-title":"Front Neurol"},{"key":"10195_CR17","doi-asserted-by":"publisher","first-page":"3603","DOI":"10.1016\/j.febslet.2011.07.043","volume":"585","author":"K-M Chavele","year":"2011","unstructured":"Chavele K-M, Ehrenstein MR (2011) Regulatory T-cells in systemic lupus erythematosus and rheumatoid arthritis. FEBS Lett 585:3603\u20133610","journal-title":"FEBS Lett"},{"key":"10195_CR18","doi-asserted-by":"publisher","first-page":"9831079","DOI":"10.1155\/2018\/9831079","volume":"2018","author":"W-H Chen","year":"2018","unstructured":"Chen W-H, Yeh H-L, Tsao C-W, Lien L-M, Chiwaya A, Alizargar J, Bai C-H (2018) Plasma Translocator Protein Levels and Outcomes of Acute Ischemic Stroke: A Pilot Study. Dis Markers 2018:9831079","journal-title":"Dis Markers"},{"key":"10195_CR19","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1007\/s00401-020-02193-z","volume":"140","author":"F Cignarella","year":"2020","unstructured":"Cignarella F, Filipello F, Bollman B, Cantoni C, Locca A, Mikesell R, Manis M, Ibrahim A, Deng L, Benitez BA, Cruchaga C, Licastro D, Mihindukulasuriya K, Harari O, Buckland M, Holtzman DM, Rosenthal A, Schwabe T, Tassi I, Piccio L (2020) TREM2 activation on microglia promotes myelin debris clearance and remyelination in a model of multiple sclerosis. Acta Neuropathol 140:513\u2013534","journal-title":"Acta Neuropathol"},{"key":"10195_CR20","doi-asserted-by":"publisher","first-page":"1059173","DOI":"10.3389\/fimmu.2022.1059173","volume":"13","author":"B Cisneros","year":"2022","unstructured":"Cisneros B, Garc\u00eda-Aguirre I, Unzueta J, Arrieta-Cruz I, Gonz\u00e1lez-Morales O, Dom\u00ednguez-Larrieta JM, Tamez-Gonz\u00e1lez A, Leyva-G\u00f3mez G, Maga\u00f1a JJ (2022) Immune system modulation in aging: Molecular mechanisms and therapeutic targets. Front Immunol 13:1059173","journal-title":"Front Immunol"},{"key":"10195_CR21","doi-asserted-by":"publisher","first-page":"E1896","DOI":"10.1073\/pnas.1800165115","volume":"115","author":"LE Clarke","year":"2018","unstructured":"Clarke LE, Liddelow SA, Chakraborty C, M\u00fcnch AE, Heiman M, Barres BA (2018) Normal aging induces A1-like astrocyte reactivity. Proc Natl Acad Sci 115:E1896\u2013E1905","journal-title":"Proc Natl Acad Sci"},{"key":"10195_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.ceb.2023.102307","volume":"86","author":"C Col\u00f3n Ortiz","year":"2024","unstructured":"Col\u00f3n Ortiz C, Eroglu C (2024) Astrocyte signaling and interactions in Multiple Sclerosis. Curr Opin Cell Biol 86:102307","journal-title":"Curr Opin Cell Biol"},{"key":"10195_CR23","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1016\/S0140-6736(08)61620-7","volume":"372","author":"A Compston","year":"2008","unstructured":"Compston A, Coles A (2008) Multiple sclerosis. The Lancet 372:1502\u20131517","journal-title":"The Lancet"},{"key":"10195_CR24","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1111\/j.1476-5381.2011.01302.x","volume":"164","author":"C Constantinescu","year":"2011","unstructured":"Constantinescu C, Farooqi N, O\u2019Brien K, Gran B (2011) Experimental autoimmune encephalomyelitis (EAE) as a model for multiple sclerosis (MS). Br J Pharmacol 164:1079\u20131106","journal-title":"Br J Pharmacol"},{"key":"10195_CR25","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.3390\/jpm11101006","volume":"11","author":"PK Coyle","year":"2021","unstructured":"Coyle PK (2021) What Can We Learn from Sex Differences in MS? J Pers Med 11:1006","journal-title":"J Pers Med"},{"key":"10195_CR26","doi-asserted-by":"publisher","first-page":"78","DOI":"10.3390\/brainsci7070078","volume":"7","author":"N Dargahi","year":"2017","unstructured":"Dargahi N, Katsara M, Tselios T, Androutsou M-E, de Courten M, Matsoukas J, Apostolopoulos V (2017) Multiple Sclerosis: Immunopathology and Treatment Update. Brain Sci 7:78","journal-title":"Brain Sci"},{"key":"10195_CR27","doi-asserted-by":"publisher","first-page":"102893","DOI":"10.1016\/j.autrev.2021.102893","volume":"20","author":"M Dema","year":"2021","unstructured":"Dema M, Eixarch H, Villar LM, Montalban X, Espejo C (2021) Immunosenescence in multiple sclerosis: the identification of new therapeutic targets. Autoimmun Rev 20:102893","journal-title":"Autoimmun Rev"},{"key":"10195_CR28","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1038\/nri3871","volume":"15","author":"CA Dendrou","year":"2015","unstructured":"Dendrou CA, Fugger L, Friese MA (2015) Immunopathology of multiple sclerosis. Nat Rev Immunol 15:545\u2013558","journal-title":"Nat Rev Immunol"},{"key":"10195_CR29","doi-asserted-by":"publisher","first-page":"748","DOI":"10.3390\/cells9030748","volume":"9","author":"G Di Sante","year":"2020","unstructured":"Di Sante G, Amadio S, Sampaolese B, Clementi ME, Valentini M, Volont\u00e9 C, Casalbore P, Ria F, Michetti F (2020) The S100B inhibitor pentamidine ameliorates clinical score and neuropathology of relapsing\u2014remitting multiple sclerosis mouse model. Cells 9:748","journal-title":"Cells"},{"key":"10195_CR30","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1038\/s41583-023-00709-6","volume":"24","author":"F Dist\u00e9fano-Gagn\u00e9","year":"2023","unstructured":"Dist\u00e9fano-Gagn\u00e9 F, Bitarafan S, Lacroix S, Gosselin D (2023) Roles and regulation of microglia activity in multiple sclerosis: insights from animal models. Nat Rev Neurosci 24:397\u2013415","journal-title":"Nat Rev Neurosci"},{"key":"10195_CR31","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/ene.13819","volume":"26","author":"R Dobson","year":"2019","unstructured":"Dobson R, Giovannoni G (2019) Multiple sclerosis \u2013 a review. Eur J Neurol 26:27\u201340","journal-title":"Eur J Neurol"},{"key":"10195_CR32","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1093\/brain\/awy352","volume":"142","author":"D Eden","year":"2019","unstructured":"Eden D, Gros C, Badji A, Dupont SM, De Leener B, Maranzano J, Zhuoquiong R, Liu Y, Granberg T, Ouellette R, Stawiarz L, Hillert J, Talbott J, Bannier E, Kerbrat A, Edan G, Labauge P, Callot V, Pelletier J, Audoin B, Rasoanandrianina H, Brisset J-C, Valsasina P, Rocca MA, Filippi M, Bakshi R, Tauhid S, Prados F, Yiannakas M, Kearney H, Ciccarelli O, Smith SA, Andrada Treaba C, Mainero C, Lefeuvre J, Reich DS, Nair G, Shepherd TM, Charlson E, Tachibana Y, Hori M, Kamiya K, Chougar L, Narayanan S, Cohen-Adad J (2019) Spatial distribution of multiple sclerosis lesions in the cervical spinal cord. Brain 142:633\u2013646","journal-title":"Brain"},{"key":"10195_CR33","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.3390\/cells10051138","volume":"10","author":"MK Edler","year":"2021","unstructured":"Edler MK, Mhatre-Winters I, Richardson JR (2021) Microglia in aging and alzheimer\u2019s disease: A comparative species review. Cells 10:1138","journal-title":"Cells"},{"key":"10195_CR34","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/s41572-018-0041-4","volume":"4","author":"M Filippi","year":"2018","unstructured":"Filippi M, Bar-Or A, Piehl F, Preziosa P, Solari A, Vukusic S, Rocca MA (2018) Multiple sclerosis. Nat Rev Dis Primers 4:43","journal-title":"Nat Rev Dis Primers"},{"key":"10195_CR35","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1038\/s41380-021-01361-1","volume":"27","author":"CE Finger","year":"2022","unstructured":"Finger CE, Moreno-Gonzalez I, Gutierrez A, Moruno-Manchon JF, McCullough LD (2022) Age-related immune alterations and cerebrovascular inflammation. Mol Psychiatry 27:803\u2013818","journal-title":"Mol Psychiatry"},{"key":"10195_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1365-2249.2010.04143.x","volume":"162","author":"JM Fletcher","year":"2010","unstructured":"Fletcher JM, Lalor SJ, Sweeney CM, Tubridy N, Mills KHG (2010) T cells in multiple sclerosis and experimental autoimmune encephalomyelitis. Clin Exp Immunol 162:1\u201311","journal-title":"Clin Exp Immunol"},{"key":"10195_CR37","doi-asserted-by":"crossref","unstructured":"Flurkey K, Mcurrer J, Harrison D (2007) Mouse Models in Aging Research. In: The Mouse in Biomedical Research. Elsevier. p 637\u2013672","DOI":"10.1016\/B978-012369454-6\/50074-1"},{"key":"10195_CR38","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/j.it.2005.08.011","volume":"26","author":"MA Friese","year":"2005","unstructured":"Friese MA, Jones EY, Fugger L (2005) MHC II molecules in inflammatory diseases: interplay of qualities and quantities. Trends Immunol 26:559\u2013561","journal-title":"Trends Immunol"},{"key":"10195_CR39","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1002\/ana.24497","volume":"78","author":"JM Frischer","year":"2015","unstructured":"Frischer JM, Weigand SD, Guo Y, Kale N, Parisi JE, Pirko I, Mandrekar J, Bramow S, Metz I, Br\u00fcck W, Lassmann H, Lucchinetti CF (2015) Clinical and pathological insights into the dynamic nature of the white matter multiple sclerosis plaque. Ann Neurol 78:710\u2013721","journal-title":"Ann Neurol"},{"key":"10195_CR40","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.1093\/brain\/awaa098","volume":"143","author":"A Gafson","year":"2020","unstructured":"Gafson A, Barth\u00e9lemy N, Bomont P, Carare R, Durham H, Julien JP, Kuhle J, Leppert D, Nixon R, Weller RO, Zetterberg H, Matthews P (2020) Neurofilaments: neurobiological foundations for biomarker applications. Brain 143:1975\u20131998","journal-title":"Brain"},{"key":"10195_CR41","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/nri2550","volume":"9","author":"J Goverman","year":"2009","unstructured":"Goverman J (2009) Autoimmune T cell responses in the central nervous system. Nat Rev Immunol 9:393\u2013407","journal-title":"Nat Rev Immunol"},{"key":"10195_CR42","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1016\/S0140-6736(19)31786-6","volume":"394","author":"EO Hoogendijk","year":"2019","unstructured":"Hoogendijk EO, Afilalo J, Ensrud KE, Kowal P, Onder G, Fried LP (2019) Frailty: implications for clinical practice and public health. Lancet 394:1365\u20131375","journal-title":"Lancet"},{"key":"10195_CR43","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/2051-5960-2-53","volume":"2","author":"G Ingram","year":"2014","unstructured":"Ingram G, Loveless S, Howell OW, Hakobyan S, Dancey B, Harris CL, Robertson NP, Neal JW, Morgan BP (2014) Complement activation in multiple sclerosis plaques: an immunohistochemical analysis. Acta Neuropathol Commun 2:53","journal-title":"Acta Neuropathol Commun"},{"key":"10195_CR44","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1159\/000355303","volume":"60","author":"A Jagger","year":"2014","unstructured":"Jagger A, Shimojima Y, Goronzy JJ, Weyand CM (2014) Regulatory T cells and the immune aging process: A mini-review. Gerontology 60:130\u2013137","journal-title":"Gerontology"},{"key":"10195_CR45","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1111\/neup.12612","volume":"40","author":"AJ Jahan-Abad","year":"2020","unstructured":"Jahan-Abad AJ, Karima S, Shateri S, Baram SM, Rajaei S, Morteza-Zadeh P, Borhani-Haghighi M, Salari A, Nikzamir A, Gorji A (2020) Serum pro-inflammatory and anti-inflammatory cytokines and the pathogenesis of experimental autoimmune encephalomyelitis. Neuropathology 40:84\u201392","journal-title":"Neuropathology"},{"key":"10195_CR46","doi-asserted-by":"publisher","first-page":"9794","DOI":"10.1523\/JNEUROSCI.2116-06.2006","volume":"26","author":"S Kaneko","year":"2006","unstructured":"Kaneko S, Wang J, Kaneko M, Yiu G, Hurrell J, Chitnis T, Khoury S, He Z (2006) Protecting axonal degeneration by increasing nicotinamide adenine dinucleotide levels in experimental autoimmune encephalomyelitis models. J Neurosci 26:9794\u20139804","journal-title":"J Neurosci"},{"key":"10195_CR47","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1111\/cen3.12591","volume":"11","author":"K Kimura","year":"2020","unstructured":"Kimura K (2020) Regulatory T cells in multiple sclerosis. Clin Exp Neuroimmunol 11:148\u2013155","journal-title":"Clin Exp Neuroimmunol"},{"key":"10195_CR48","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1007\/s00415-008-0778-x","volume":"255","author":"B Kis","year":"2008","unstructured":"Kis B, Rumberg B, Berlit P (2008) Clinical characteristics of patients with late-onset multiple sclerosis. J Neurol 255:697\u2013702","journal-title":"J Neurol"},{"key":"10195_CR49","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1523\/JNEUROSCI.2615-05.2006","volume":"26","author":"MR Kotter","year":"2006","unstructured":"Kotter MR (2006) Myelin impairs CNS remyelination by inhibiting oligodendrocyte precursor cell differentiation. J Neurosci 26:328\u2013332","journal-title":"J Neurosci"},{"key":"10195_CR50","doi-asserted-by":"publisher","first-page":"265","DOI":"10.2174\/1570159X18666200729100427","volume":"19","author":"U Langeh","year":"2020","unstructured":"Langeh U, Singh S (2020) Targeting S100B protein as a surrogate biomarker and its role in various neurological disorders. Curr Neuropharmacol 19:265\u2013277","journal-title":"Curr Neuropharmacol"},{"key":"10195_CR51","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.ceb.2015.01.003","volume":"32","author":"A Laser-Azogui","year":"2015","unstructured":"Laser-Azogui A, Kornreich M, Malka-Gibor E, Beck R (2015) Neurofilament assembly and function during neuronal development. Curr Opin Cell Biol 32:92\u2013101","journal-title":"Curr Opin Cell Biol"},{"key":"10195_CR52","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/s00401-016-1631-4","volume":"133","author":"H Lassmann","year":"2017","unstructured":"Lassmann H, Bradl M (2017) Multiple sclerosis: experimental models and reality. Acta Neuropathol 133:223\u2013244","journal-title":"Acta Neuropathol"},{"key":"10195_CR53","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1038\/s43587-023-00479-x","volume":"3","author":"X Li","year":"2023","unstructured":"Li X, Li Y, Jin Y, Zhang Y, Wu J, Xu Z, Huang Y, Cai L, Gao S, Liu T, Zeng F, Wang Y, Wang W, Yuan T-F, Tian H, Shu Y, Guo F, Lu W, Mao Y, Mei X, Rao Y, Peng B (2023) Transcriptional and epigenetic decoding of the microglial aging process. Nat Aging 3:1288\u20131311","journal-title":"Nat Aging"},{"key":"10195_CR54","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/nature21029","volume":"541","author":"SA Liddelow","year":"2017","unstructured":"Liddelow SA, Guttenplan KA, Clarke LE, Bennett FC, Bohlen CJ, Schirmer L, Bennett ML, M\u00fcnch AE, Chung W-S, Peterson TC, Wilton DK, Frouin A, Napier BA, Panicker N, Kumar M, Buckwalter MS, Rowitch DH, Dawson VL, Dawson TM, Stevens B, Barres BA (2017) Neurotoxic reactive astrocytes are induced by activated microglia. Nature 541:481\u2013487","journal-title":"Nature"},{"key":"10195_CR55","doi-asserted-by":"publisher","first-page":"1197212","DOI":"10.3389\/fneur.2023.1197212","volume":"14","author":"G Macaron","year":"2023","unstructured":"Macaron G, Larochelle C, Arbour N, Galmard M, Girard JM, Prat A, Duquette P (2023) Impact of aging on treatment considerations for multiple sclerosis patients. Front Neurol 14:1197212","journal-title":"Front Neurol"},{"key":"10195_CR56","doi-asserted-by":"publisher","first-page":"267","DOI":"10.4103\/1673-5374.346538","volume":"18","author":"V Mancini","year":"2023","unstructured":"Mancini V, Di Pietro A, Pasquini L (2023) Microglia depletion as a therapeutic strategy: friend or foe in multiple sclerosis models? Neural Regen Res 18:267\u2013272","journal-title":"Neural Regen Res"},{"key":"10195_CR57","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1016\/j.tig.2021.04.012","volume":"37","author":"R Martin","year":"2021","unstructured":"Martin R, Sospedra M, Eiermann T, Olsson T (2021) Multiple sclerosis: doubling down on MHC. Trends Genet 37:784\u2013797","journal-title":"Trends Genet"},{"key":"10195_CR58","doi-asserted-by":"publisher","first-page":"2387","DOI":"10.4049\/jimmunol.174.4.2387","volume":"174","author":"A Matejuk","year":"2005","unstructured":"Matejuk A, Hopke C, Vandenbark AA, Hurn PD, Offner H (2005) Middle-age male mice have increased severity of experimental autoimmune encephalomyelitis and are unresponsive to testosterone therapy. J Immunol 174:2387\u20132395","journal-title":"J Immunol"},{"key":"10195_CR59","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1111\/jnc.14574","volume":"148","author":"F Michetti","year":"2019","unstructured":"Michetti F, D\u2019Ambrosi N, Toesca A, Puglisi MA, Serrano A, Marchese E, Corvino V, Geloso MC (2019) The S100B story: from biomarker to active factor in neural injury. J Neurochem 148:168\u2013187","journal-title":"J Neurochem"},{"key":"10195_CR60","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/j.bbi.2010.01.014","volume":"24","author":"\u00c1C Murphy","year":"2010","unstructured":"Murphy \u00c1C, Lalor SJ, Lynch MA, Mills KHG (2010) Infiltration of Th1 and Th17 cells and activation of microglia in the CNS during the course of experimental autoimmune encephalomyelitis. Brain Behav Immun 24:641\u2013651","journal-title":"Brain Behav Immun"},{"key":"10195_CR61","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fnagi.2018.00238","volume":"10","author":"A Musella","year":"2018","unstructured":"Musella A, Gentile A, Rizzo FR, De VF, Fresegna D, Bullitta S, Vanni V, Guadalupi L, Bassi MS, Buttari F, Centonze D, Mandolesi G (2018) Interplay between age and neuroinflammation in multiple sclerosis: Effects on motor and cognitive functions. Front Aging Neurosci 10:1\u201313","journal-title":"Front Aging Neurosci"},{"key":"10195_CR62","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1177\/1352458519884006","volume":"25","author":"B Neumann","year":"2019","unstructured":"Neumann B, Segel M, Chalut K, Franklin R (2019) Remyelination and ageing: Reversing the ravages of time. Mult Scler 25:1835\u20131841","journal-title":"Mult Scler"},{"key":"10195_CR63","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1038\/npp.2016.185","volume":"42","author":"A Niraula","year":"2017","unstructured":"Niraula A, Sheridan JF, Godbout JP (2017) Microglia priming with aging and stress. Neuropsychopharmacology 42:318\u2013333","journal-title":"Neuropsychopharmacology"},{"key":"10195_CR64","doi-asserted-by":"publisher","first-page":"6586","DOI":"10.4049\/jimmunol.176.11.6586","volume":"176","author":"T Nishioka","year":"2006","unstructured":"Nishioka T, Shimizu J, Iida R, Yamazaki S, Sakaguchi S (2006) CD4+CD25+Foxp3+ T cells and CD4+CD25-Foxp3+ T cells in aged mice. J Immunol 176:6586\u20136593","journal-title":"J Immunol"},{"key":"10195_CR65","doi-asserted-by":"publisher","first-page":"332","DOI":"10.4049\/jimmunol.0900691","volume":"183","author":"WE O\u2019Gorman","year":"2009","unstructured":"O\u2019Gorman WE, Dooms H, Thorne SH, Kuswanto WF, Simonds EF, Krutzik PO, Nolan GP, Abbas AK (2009) The initial phase of an immune response functions to activate regulatory T cells. J Immunol 183:332\u2013339","journal-title":"J Immunol"},{"key":"10195_CR66","doi-asserted-by":"publisher","first-page":"337","DOI":"10.3389\/fnagi.2018.00337","volume":"10","author":"AL Palmer","year":"2018","unstructured":"Palmer AL, Ousman SS (2018) Astrocytes and aging. Front Aging Neurosci 10:337","journal-title":"Front Aging Neurosci"},{"key":"10195_CR67","doi-asserted-by":"publisher","first-page":"178","DOI":"10.3389\/fncel.2020.00178","volume":"14","author":"D Papadopoulos","year":"2020","unstructured":"Papadopoulos D, Magliozzi R, Mitsikostas DD, Gorgoulis VG, Nicholas RS (2020) Aging, cellular senescence, and progressive multiple sclerosis. Front Cell Neurosci 14:178","journal-title":"Front Cell Neurosci"},{"key":"10195_CR68","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1111\/imm.12644","volume":"149","author":"LAN Peferoen","year":"2016","unstructured":"Peferoen LAN, Breur M, van de Berg S, Peferoen-Baert R, Boddeke EHWGM, van der Valk P, Pryce G, van Noort JM, Baker D, Amor S (2016) Ageing and recurrent episodes of neuroinflammation promote progressive experimental autoimmune encephalomyelitis in Biozzi ABH mice. Immunology 149:146\u2013156","journal-title":"Immunology"},{"key":"10195_CR69","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1093\/brain\/awf165","volume":"125","author":"A Petzold","year":"2002","unstructured":"Petzold A (2002) Markers for different glial cell responses in multiple sclerosis: clinical and pathological correlations. Brain 125:1462\u20131473","journal-title":"Brain"},{"key":"10195_CR70","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1002\/eji.200636837","volume":"37","author":"L Piccio","year":"2007","unstructured":"Piccio L, Buonsanti C, Mariani M, Cella M, Gilfillan S, Cross AH, Colonna M, Panina-Bordignon P (2007) Blockade of TREM-2 exacerbates experimental autoimmune encephalomyelitis. Eur J Immunol 37:1290\u20131301","journal-title":"Eur J Immunol"},{"key":"10195_CR71","doi-asserted-by":"publisher","first-page":"5960","DOI":"10.3390\/ijms21175960","volume":"21","author":"MV Pinto","year":"2020","unstructured":"Pinto MV, Fernandes A (2020) Microglial phagocytosis\u2014rational but challenging therapeutic target in multiple sclerosis. Int J Mol Sci 21:5960","journal-title":"Int J Mol Sci"},{"key":"10195_CR72","doi-asserted-by":"publisher","first-page":"3163","DOI":"10.3390\/cells10113163","volume":"10","author":"MV Pinto","year":"2021","unstructured":"Pinto MV, Santos FMF, Barros C, Ribeiro AR, Pischel U, Gois PMP, Fernandes A (2021) BASHY dye platform enables the fluorescence bioimaging of myelin debris phagocytosis by microglia during demyelination. Cells 10:3163","journal-title":"Cells"},{"key":"10195_CR73","doi-asserted-by":"publisher","first-page":"217","DOI":"10.3389\/fimmu.2018.00217","volume":"9","author":"G Ponath","year":"2018","unstructured":"Ponath G, Park C, Pitt D (2018) The role of astrocytes in multiple sclerosis. Front Immunol 9:217","journal-title":"Front Immunol"},{"key":"10195_CR74","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1093\/clinchem\/48.6.950","volume":"48","author":"LVC Portela","year":"2002","unstructured":"Portela LVC, Tort ABL, Schaf DV, Ribeiro L, Nora DB, Walz R, Rotta LN, Silva CT, Busnello JV, Kapczinski F, Gon\u00e7alves CA, Souza DO (2002) The serum S100B concentration is age dependent. Clin Chem 48:950\u2013952","journal-title":"Clin Chem"},{"key":"10195_CR75","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.cyto.2014.09.011","volume":"74","author":"I Raphael","year":"2015","unstructured":"Raphael I, Nalawade S, Eagar TN, Forsthuber TG (2015) T cell subsets and their signature cytokines in autoimmune and inflammatory diseases. Cytokine 74:5\u201317","journal-title":"Cytokine"},{"key":"10195_CR76","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/gerona\/glab185","volume":"77","author":"AR Ribeiro","year":"2022","unstructured":"Ribeiro AR, Barros C, Barateiro A, Howlett SE, Fernandes A (2022) Improved assessment of overall health in variably aged murine models of multiple sclerosis with a novel frailty index tool. J Gerontol: Ser A 77:1\u20139","journal-title":"J Gerontol: Ser A"},{"key":"10195_CR77","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/B978-0-444-52001-2.00008-X","volume":"122","author":"AP Robinson","year":"2014","unstructured":"Robinson AP, Harp CT, Noronha A, Miller SD (2014) The experimental autoimmune encephalomyelitis (EAE) model of MS: utility for understanding disease pathophysiology and treatment. Handb Clin Neurol 122:173\u2013189","journal-title":"Handb Clin Neurol"},{"key":"10195_CR78","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1093\/gerona\/59.12.1310","volume":"59","author":"K Rockwood","year":"2004","unstructured":"Rockwood K, Howlett SE, MacKnight C, Beattie BL, Bergman H, H\u00e9bert R, Hogan DB, Wolfson C, McDowell I (2004) Prevalence, attributes, and outcomes of fitness and frailty in community-dwelling older adults: Report from the Canadian study of health and aging. J Gerontol: Ser A 59:1310\u20131317","journal-title":"J Gerontol: Ser A"},{"key":"10195_CR79","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/1742-2094-7-78","volume":"7","author":"E Roltsch","year":"2010","unstructured":"Roltsch E, Holcomb L, Young KA, Marks A, Zimmer DB (2010) PSAPP mice exhibit regionally selective reductions in gliosis and plaque deposition in response to S100B ablation. J Neuroinflammation 7:78","journal-title":"J Neuroinflammation"},{"key":"10195_CR80","doi-asserted-by":"publisher","first-page":"105008","DOI":"10.1016\/j.nbd.2020.105008","volume":"143","author":"IH Salas","year":"2020","unstructured":"Salas IH, Burgado J, Allen NJ (2020) Glia: victims or villains of the aging brain? Neurobiol Dis 143:105008","journal-title":"Neurobiol Dis"},{"key":"10195_CR81","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.neuropharm.2017.11.002","volume":"129","author":"G Santos","year":"2018","unstructured":"Santos G, Barateiro A, Gomes CM, Brites D, Fernandes A (2018) Impaired oligodendrogenesis and myelination by elevated S100B levels during neurodevelopment. Neuropharmacology 129:69\u201383","journal-title":"Neuropharmacology"},{"key":"10195_CR82","doi-asserted-by":"publisher","first-page":"279","DOI":"10.3389\/fncel.2020.00279","volume":"14","author":"G Santos","year":"2020","unstructured":"Santos G, Barateiro A, Brites D, Fernandes A (2020) S100B impairs oligodendrogenesis and myelin repair following demyelination through rage engagement. Front Cell Neurosci 14:279","journal-title":"Front Cell Neurosci"},{"key":"10195_CR83","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.it.2021.01.005","volume":"42","author":"L Schirmer","year":"2021","unstructured":"Schirmer L, Schafer DP, Bartels T, Rowitch DH, Calabresi PA (2021) Diversity and function of glial cell types in multiple sclerosis. Trends Immunol 42:228\u2013247","journal-title":"Trends Immunol"},{"key":"10195_CR84","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.jneuroim.2015.08.005","volume":"287","author":"J-E Seo","year":"2015","unstructured":"Seo J-E, Hasan M, Han J-S, Kang M-J, Jung B-H, Kwok S-K, Kim H-Y, Kwon O-S (2015) Experimental autoimmune encephalomyelitis and age-related correlations of NADPH oxidase, MMP-9, and cell adhesion molecules: The increased disease severity and blood\u2013brain barrier permeability in middle-aged mice. J Neuroimmunol 287:43\u201353","journal-title":"J Neuroimmunol"},{"key":"10195_CR85","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1111\/j.1532-5415.2010.02764.x","volume":"58","author":"X Song","year":"2010","unstructured":"Song X, Mitnitski A, Rockwood K (2010) Prevalence and 10-Year Outcomes of Frailty in Older Adults in Relation to Deficit Accumulation. J Am Geriatr Soc 58:681\u2013687","journal-title":"J Am Geriatr Soc"},{"key":"10195_CR86","doi-asserted-by":"publisher","first-page":"100913","DOI":"10.1016\/j.xcrm.2022.100913","volume":"4","author":"M Spatola","year":"2023","unstructured":"Spatola M, Chuquisana O, Jung W, Lopez JA, Wendel E-M, Ramanathan S, Keller CW, Hahn T, Meinl E, Reindl M, Dale RC, Wiendl H, Lauffenburger DA, Rost\u00e1sy K, Brilot F, Alter G, L\u00fcnemann JD (2023) Humoral signatures of MOG-antibody-associated disease track with age and disease activity. Cell Rep Med 4:100913","journal-title":"Cell Rep Med"},{"key":"10195_CR87","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1084\/jem.20041611","volume":"201","author":"K Takahashi","year":"2005","unstructured":"Takahashi K, Rochford CDP, Neumann H (2005) Clearance of apoptotic neurons without inflammation by microglial triggering receptor expressed on myeloid cells-2. J Exp Med 201:647\u2013657","journal-title":"J Exp Med"},{"key":"10195_CR88","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1007\/s12026-017-8961-8","volume":"65","author":"A Tatomir","year":"2017","unstructured":"Tatomir A, Talpos-Caia A, Anselmo F, Kruszewski AM, Boodhoo D, Rus V, Rus H (2017) The complement system as a biomarker of disease activity and response to treatment in multiple sclerosis. Immunol Res 65:1103\u20131109","journal-title":"Immunol Res"},{"key":"10195_CR89","doi-asserted-by":"publisher","first-page":"760","DOI":"10.3389\/fimmu.2020.00760","volume":"11","author":"J van Langelaar","year":"2020","unstructured":"van Langelaar J, Rijvers L, Smolders J, van Luijn MM (2020) B and T cells driving multiple sclerosis: Identity. Mechanisms and Potential Triggers. Front Immunol 11:760","journal-title":"Mechanisms and Potential Triggers. Front Immunol"},{"key":"10195_CR90","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/s41582-019-0183-3","volume":"15","author":"CB Vaughn","year":"2019","unstructured":"Vaughn CB, Jakimovski D, Kavak KS, Ramanathan M, Benedict RHB, Zivadinov R, Weinstock-Guttman B (2019) Epidemiology and treatment of multiple sclerosis in elderly populations. Nat Rev Neurol 15:329\u2013342","journal-title":"Nat Rev Neurol"},{"key":"10195_CR91","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.nbd.2011.09.008","volume":"45","author":"EV Vo\u00df","year":"2012","unstructured":"Vo\u00df EV, \u0160kuljec J, Gudi V, Skripuletz T, Pul R, Trebst C, Stangel M (2012) Characterisation of microglia during de- and remyelination: Can they create a repair promoting environment? Neurobiol Dis 45:519\u2013528","journal-title":"Neurobiol Dis"},{"key":"10195_CR92","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1172\/JCI132531","volume":"130","author":"CA Wagner","year":"2019","unstructured":"Wagner CA, Roqu\u00e9 PJ, Mileur TR, Liggitt D, Goverman JM (2019) Myelin-specific CD8+ T cells exacerbate brain inflammation in CNS autoimmunity. J Clin Investig 130:203\u2013213","journal-title":"J Clin Investig"},{"key":"10195_CR93","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1006\/exnr.1999.7260","volume":"161","author":"SD Webster","year":"2000","unstructured":"Webster SD, Yang AJ, Margol L, Garzon-Rodriguez W, Glabe CG, Tenner AJ (2000) Complement Component C1q Modulates the Phagocytosis of A\u03b2 by Microglia. Exp Neurol 161:127\u2013138","journal-title":"Exp Neurol"},{"key":"10195_CR94","doi-asserted-by":"publisher","first-page":"312","DOI":"10.3389\/fneur.2017.00312","volume":"8","author":"A Wilkins","year":"2017","unstructured":"Wilkins A (2017) Cerebellar dysfunction in multiple sclerosis. Front Neurol 8:312","journal-title":"Front Neurol"},{"key":"10195_CR95","doi-asserted-by":"crossref","unstructured":"Wood H (2021) TSPO levels in multiple sclerosis lesions reflect microglial density rather than activation state. Nat Rev Neurol 17:462","DOI":"10.1038\/s41582-021-00533-5"},{"key":"10195_CR96","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1002\/eji.201847540","volume":"48","author":"Y Wolf","year":"2018","unstructured":"Wolf Y, Shemer A, Levy-Efrati L, Gross M, Kim J-S, Engel A, David E, Chappell-Maor L, Grozovski J, Rotkopf R, Biton I, Eilam-Altstadter R, Jung S (2018) Microglial MHC class II is dispensable for experimental autoimmune encephalomyelitis and cuprizone-induced demyelination. Eur J Immunol 48:1308\u20131318","journal-title":"Eur J Immunol"},{"key":"10195_CR97","doi-asserted-by":"publisher","first-page":"986","DOI":"10.3389\/fphar.2020.00986","volume":"11","author":"R Yao","year":"2020","unstructured":"Yao R, Pan R, Shang C, Li X, Cheng J, Xu J, Li Y (2020) Translocator protein 18 kDa (TSPO) deficiency inhibits microglial activation and impairs mitochondrial function. Front Pharmacol 11:986","journal-title":"Front Pharmacol"},{"key":"10195_CR98","doi-asserted-by":"publisher","first-page":"766267","DOI":"10.3389\/fnagi.2021.766267","volume":"13","author":"H-J Yoo","year":"2022","unstructured":"Yoo H-J, Kwon M-S (2022) Aged microglia in neurodegenerative diseases: Microglia lifespan and culture methods. Front Aging Neurosci 13:766267","journal-title":"Front Aging Neurosci"},{"key":"10195_CR99","doi-asserted-by":"publisher","first-page":"4091","DOI":"10.1073\/pnas.0408679102","volume":"102","author":"S Zelenay","year":"2005","unstructured":"Zelenay S, Lopes-Carvalho T, Caramalho I, Moraes-Fontes MF, Rebelo M, Demengeot J (2005) Foxp3+ CD25- CD4 T cells constitute a reservoir of committed regulatory cells that regain CD25 expression upon homeostatic expansion. Proc Natl Acad Sci U S A 102:4091\u20134096","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10195_CR100","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1080\/08830185.2020.1797005","volume":"40","author":"M Zohouri","year":"2021","unstructured":"Zohouri M, Mehdipour F, Razmkhah M, Faghih Z, Ghaderi A (2021) CD4+CD25-FoxP3+ T cells: a distinct subset or a heterogeneous population? Int Rev Immunol 40:307\u2013316","journal-title":"Int Rev Immunol"}],"container-title":["Journal of Neuroimmune Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11481-025-10195-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11481-025-10195-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11481-025-10195-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,14]],"date-time":"2025-04-14T08:04:18Z","timestamp":1744617858000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11481-025-10195-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,14]]},"references-count":100,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["10195"],"URL":"https:\/\/doi.org\/10.1007\/s11481-025-10195-5","relation":{},"ISSN":["1557-1904"],"issn-type":[{"type":"electronic","value":"1557-1904"}],"subject":[],"published":{"date-parts":[[2025,4,14]]},"assertion":[{"value":"6 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Animal care followed the recommendations of the European Convention for the Protection of Vertebrate Animals Used for Experimental and other Scientific Purposes (Council Directive 86\/609\/EEC) and National Law 1005\/92 (rules for protection of experimental animals). All animal procedures were approved by the Institutional Animal Care and Use Committee and the National Animal Affairs Regulatory Office (Dire\u00e7\u00e3o Geral de Alimenta\u00e7\u00e3o e Veterin\u00e1ria).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"37"}}